Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Martin Meglasson > Profile

Martin Meglasson

Affiliations

Chief Scientific Officer at Bellerophon Therapeutics Inc. (BLPH), 2015-05-22
V-P, Discovery Research at Ligand Pharmaceuticals Inc (LGND), 2010-05-11

Insider Trading: Purchases See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Bellerophon Therapeutics Inc.	BLPH	$8.40	712	Officer	19,098	2015-05-20	Filing
Bellerophon Therapeutics Inc.	BLPH	$12.00	12,000	Officer	18,386	2015-02-19	Filing
Ligand Pharmaceuticals Inc	LGND	$1.63	6,250	Officer	102,250	2010-05-11	Filing